Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors
Clinical trial NCT06462222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06462222
- Sponsor
- Guangzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2026-07-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.